Table 1.
miR-675-5p expression and clinicopathological features in non-small cell lung cancer(NSCLC) patients
Variable | miR-675-5p expression | |||
---|---|---|---|---|
Cases | Low | High | P-value a | |
Age(years)b | ||||
<57 | 58 | 43 (74%) | 15 (26%) | 0.8998 |
≥57 | 22 | 16 (73%) | 6 (27%) | |
Gender | ||||
Male | 33 | 24 (73%) | 9 (27%) | 0.8750 |
Female | 47 | 35 (74%) | 12 (26%) | |
Smoking history (years)b | ||||
<10 | 36 | 24 (67%) | 12 (33%) | 0.2094 |
≥10 | 44 | 35 (80%) | 9 (20%) | |
Pathological type | ||||
adenocarcinoma | 38 | 30 (79%) | 8 (21%) | 0.3391 |
squamous carcinoma | 42 | 29 (69%) | 13 (71%) | |
Tumor differentiation | ||||
I + II | 46 | 37 (80%) | 9 (20%) | 0.0787 |
III + IV | 34 | 22 (65%) | 12 (35%) | |
TNM Classification | ||||
I | 35 | 19 (54%) | 16 (46%) | <0.005 |
II | 27 | 24 (89%) | 3 (11%) | |
III + IV | 18 | 16 (89%) | 2 (11%) | |
Metastasis | ||||
No | 44 | 27 (61%) | 17 (39%) | 0.0055 |
Yes | 36 | 32 (89%) | 4 (11%) |
Abbreviations: TNM, tumor-node-metastasis; a×2test. bMean age.